Skip to main content

MARSHALL WACE, LLP

Position in ANNX — Annexon, Inc.

CIK 1318757 LONDON, X0

Position in ANNX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$4,772,569
+$2,157,160 QoQ
Shares Held
861,475
+65.4% QoQ
Ownership
0.432%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
12 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in ANNX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $2,766,756,129 across 280 Biotechnology names. ANNX ranks #105 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ANNX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,772,569 861,475
2025-12-31 $2,615,409 520,998
2025-06-30 $71,973 29,989
2024-12-31 $199,274 38,845
2024-09-30 $1,730,853 292,374
2024-06-30 $8,298,958 1,693,665
2024-03-31 $2,262,938 315,612
2023-03-31 $1,789,553 464,819
2022-12-31 $149,185 28,856
2022-06-30 $56,402 14,961
2022-03-31 $76,909 28,172
2021-12-31 $71,927 6,260